Mohammad Hojjat‐Farsangi
12 ta ish
Karolinska Institute
Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer
Vahid Karpisheh, Afshin Nikkhoo, Mohammad Hojjat‐Farsangi +7
Sharh maqola20196 iqtibosABIEP4 receptor as a novel promising therapeutic target in colon cancer
Vahid Karpisheh, Navneet Joshi, Angelina Olegovna Zekiy +5
Sharh maqola20206 iqtibosABIThe molecular biology and therapeutic potential of Nrf2 in leukemia
Atefeh Khodakarami, Sara Adibfar, Vahid Karpisheh +6
Sharh maqola20225 iqtibosABIIncreased susceptibility to doxorubicin-induced cell death in acute lymphocytic leukemia cells by inhibiting serine/threonine WEE1 kinase expression using the chitosan-carboxymethyl dextran-polyethylene glycol-TAT nanoparticles
Abbas Ali Hosseinpour Feizi, Sajjad Vakili‐Samiani, Vahid Karpisheh +11
MaqolaOchiq kirish20224 iqtibosABIThe role of <scp>SF3B1</scp> and <scp>NOTCH1</scp> in the pathogenesis of leukemia
Shiva Abolhasani, Seyyed Sina Hejazian, Vahid Karpisheh +5
Sharh maqola20224 iqtibosABI